Original ArticlesHigh-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-Peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea
Introduction
Diabetes mellitus is a disorder of the metabolism caused by an absolute (type 1) or a relative (type 2) lack of insulin. It has been estimated that approximately 10% of hospitalized patients have diabetes.1 Eighty-five percent of these individuals have type 2 diabetes: non–insulin-dependent diabetes mellitus.
Diabetics are as likely to develop problems requiring nutritional support as are people who do not have diabetes. If diabetic patients are unable to ingest nutrients orally but the gastrointestinal tract is still functional, enteral feeding is the choice for nutritional support.2
Most standard enteral formulae are low in fiber, and fat and carbohydrates constitute the largest percentage of energy (45–92%).3 Two commercial enteral formulae specific for diabetic patients are now available in Spain: a high-complex-carbohydrate enteral formula (HCF), and a reduced carbohydrate modified formula (RCF).
The definition of an optimal diet for individuals with diabetes mellitus is the subject of considerable debate. There are two opposing views.4 The prevailing view is that diabetic patients should follow a low-fat diet5 such as HCF. However, the results of some studies (Table I) 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 have been considered by the American Diabetes Association (ADA), and the latest dietary recommendations16 allow monounsaturated fats and carbohydrates to constitute from 60 to 70% of the total caloric content of the diet, as in RCF.
Use of enteral nutritional supplementation in elderly nursing home patients with type 2 diabetes tends to exacerbate hyperglycemia and requires initiation or increase of insulin therapy.17 It would be of interest to use a supplemental enteral formula with the fewest possible side effects on metabolic control. In a previous study,18 we found that the glycemic response to a breakfast test was lower with RCF than with HCF. In this study, the effects of these two enteral diets are compared, not only on glycemic response, but also on insulin production and ketone suppression in type 2 diabetes treated with insulin or sulfonylureas.
Section snippets
Patients and methods
Fifty-two type 2 diabetes volunteers (64% females, ages 45–72 y, mean age 65 ± 7 y) with a good glycemic control (mean HbA1c 6.5 ± 0.9%) were selected for this study. None of the patients had a history of ketosis, brittle diabetes, or thyroidal, renal, or hepatic diseases. All had reported an insidious onset of diabetes with minimal symptoms, with the following means: type 2 diabetes duration 12 ± 5 y, body mass index 29.2 ± 2.7, triacylglycerols 151 ± 50 mg/dL, and total cholesterol 238 ± 39
Results
Age, duration of diabetes, insulin requirements, glycosylated hemoglobin concentrations, body mass index, and plasma levels of triacylglycerols and total cholesterol were similar in all groups.
The mean plasma levels in fasting and 30 and 120 min after ingestion of the two liquid formulae are shown in Table III and Figure 1, and the mean increments above basal levels in Table IV.
The mean glucose values were significantly higher for insulin-treated groups (HCF-i versus RCF-i) 120 min after the
Discussion
The best diet for diabetic patients has been a controversial issue for many years and the dietary recommendations to patients with diabetes mellitus have changed from the diets extremely rich in carbohydrates recommended by the ADA in 19865 to the 1994 ADA guidelines for individualizing the dietary prescription.16
The major emphasis of the ADA recommendations in 19865 was to reduce saturated fats to below 10% of the total energy intake and dietary cholesterol to below 300 mg/d with a view to
References (38)
- et al.
Utilization trends and risk factors for hospitalization in diabetes mellitus
Mayo Clin Proc
(1990) - et al.
Carbohydrate and lipid metabolism in patients with non–insulin-dependent diabetes mellituseffects of a low-fat, high-carbohydrate diet vs a diet high in monounsaturated fatty acids
Am J Clin Nutr
(1991) - et al.
A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non–insulin-dependent diabetic patients
Metabolism
(1992) - et al.
Nutrition support in hospitalized patients with diabetes mellitus. Concise review for primary-care physicians
Mayo Clin Proc
(1996) - et al.
Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes
Am J Med
(1989) - et al.
Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non–insulin-dependent diabetes mellitus
Am J Clin Nutr
(1996) - et al.
Management of diabetic patients requiring nutritional support
Nutrition
(1992) Formulas
Dietary therapy in diabetes mellitusis there a single best diet?
Diabetes Care
(1991)Nutritional recommendations and principles for individuals with diabetes mellitus1986
Diabetes Care
(1987)
Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non–insulin-dependent diabetes mellitus
N Engl J Med
Long-term effects of high-carbohydrate versus high-monounsaturated-fat diets in NIDDM
Diabetes
Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM
Diabetes
Lipoprotein compositional changes in the fasting and postprandial state on a high-carbohydrate low-fat and a high-fat diet in subjets with noninsulin-dependent diabetes mellitus
J Clin Endocrinol Metab
Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects
Diabetes Care
Effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients
Diabetes Care
The high-monounsaturated fat diet as a practical alternative for NIDDM
Diabetes Care
Effects of varying carbohydrate content of diet in patients with non–insulin-dependent diabetes mellitus
JAMA
Position Statement. Nutrition recommendations and principles for people with diabetes mellitus
Diabetes Care
Cited by (39)
Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia. A systematic review and meta-analysis
2020, Clinical NutritionCitation Excerpt :The characteristics of the included studies are shown in Table 1. In the eight postprandial response studies, formula was administered orally [20–25], except in two of the studies, in which it was provided as a tube feed [19,26]. With regard to hypoglycaemic treatment, patients with DM were treated with oral antidiabetic drugs (DM-oa) [19,20,22–25], except in two studies [21,26], in which some patients received insulin (DM-i).
Usefulness of liquid ketogenic milk for intractable childhood epilepsy
2010, e-SPENCitation Excerpt :A ketogenic diet liquefied by a food-mixer was already suggested that it is perhaps the easiest method of providing the diet, in particular for infants that are formula fed, handicapped children with Levine tube, as well as for older children with gastrostomy tubes. Now, two kinds of powered formula of ketogenic milk to be liquefied by water have been also developed.5,6 This ketogenic milk is the first and only commercially available liquid formula that is used exclusively for KD treatment.
Administration of a new diabetes-specific enteral formula results in an improved 24 h glucose profile in type 2 diabetic patients
2009, Diabetes Research and Clinical PracticeCitation Excerpt :A systematic review showed that use of diabetes-specific formulas is associated with improved glycaemic control compared with standard formulas [10]. Most postprandial studies with diabetes-specific formulas in type 2 diabetes patients, studied the postprandial glucose levels after a single bolus of the diabetes-specific formula [11,12,13] or studied one time point (2 h) after intake for breakfast, lunch and dinner [14]. Until now, no study has determined the effect of several boluses of a diabetes-specific formula on 24 h glucose profiles.
Long-term use of a diabetes-specific oral nutritional supplement results in a low-postprandial glucose response in diabetes patients
2008, Diabetes Research and Clinical PracticeCitation Excerpt :The beneficial effect on postprandial glucose responses after a single bolus of the presently tested diabetes-specific ONS has already been shown in type 2 diabetes patients and healthy volunteers [9]. Also, other studies with comparable high-MUFA, low-carbohydrate ONS demonstrated a reduced postprandial glycaemic response after single consumption [11,12]. The present study showed that after long-term consumption, the diabetes-specific ONS resulted in a further reduction of the postprandial glucose response, as demonstrated by the decrease of the delta postprandial peak glucose (p < 0.05) and of the AUC4 (p = 0.074) after 12 weeks compared with baseline within the diabetes-specific ONS group, but not within the standard ONS group.
Enteral nutrition formulas in diabetes mellitus
2005, Endocrinologia y NutricionClinical evidence on nutritional support in diabetes: A systematic review
2005, Endocrinologia y Nutricion